A citation-based method for searching scientific literature

Alan Menter, Matthias Augustin, James Signorovitch, Andrew P Yu, Eric Q Wu, Shiraz R Gupta, Yanjun Bao, Parvez Mulani. J Am Acad Dermatol 2010
Times Cited: 94







List of co-cited articles
2091 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
Stephen Tyring, Alice Gottlieb, Kim Papp, Ken Gordon, Craig Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik,[...]. Lancet 2006
726
64

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Richard G Langley, Steven R Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming-Chun Hsu, Jean-Paul Ortonne, Kenneth B Gordon, Alexa B Kimball. J Am Acad Dermatol 2010
118
47

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
37

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
Charles L Raison, Robin E Rutherford, Bobbi J Woolwine, Chen Shuo, Pamela Schettler, Daniel F Drake, Ebrahim Haroon, Andrew H Miller. JAMA Psychiatry 2013
859
31

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
26

From inflammation to sickness and depression: when the immune system subjugates the brain.
Robert Dantzer, Jason C O'Connor, Gregory G Freund, Rodney W Johnson, Keith W Kelley. Nat Rev Neurosci 2008
25

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
24

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials.
Ole Köhler, Michael E Benros, Merete Nordentoft, Michael E Farkouh, Rupa L Iyengar, Ole Mors, Jesper Krogh. JAMA Psychiatry 2014
441
22

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
N Müller, M J Schwarz, S Dehning, A Douhe, A Cerovecki, B Goldstein-Müller, I Spellmann, G Hetzel, K Maino, N Kleindienst,[...]. Mol Psychiatry 2006
511
20

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Alan Menter, Stephen K Tyring, Kenneth Gordon, Alexa B Kimball, Craig L Leonardi, Richard G Langley, Bruce E Strober, Martin Kaul, Yihua Gu, Martin Okun,[...]. J Am Acad Dermatol 2008
597
19

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.
Shanu Kohli Kurd, Andrea B Troxel, Paul Crits-Christoph, Joel M Gelfand. Arch Dermatol 2010
399
19

Cytokines sing the blues: inflammation and the pathogenesis of depression.
Charles L Raison, Lucile Capuron, Andrew H Miller. Trends Immunol 2006
17

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.
R Krishnan, D Cella, C Leonardi, K Papp, A B Gottlieb, M Dunn, C F Chiou, V Patel, A Jahreis. Br J Dermatol 2007
86
18

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Seyed-Hesameddin Abbasi, Fahimeh Hosseini, Amirhossein Modabbernia, Mandana Ashrafi, Shahin Akhondzadeh. J Affect Disord 2012
185
17

Cytokine production and treatment response in major depressive disorder.
S Lanquillon, J C Krieg, U Bening-Abu-Shach, H Vedder. Neuropsychopharmacology 2000
502
15

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Jonas Hannestad, Nicole DellaGioia, Michael Bloch. Neuropsychopharmacology 2011
543
15

Psoriasis causes as much disability as other major medical diseases.
S R Rapp, S R Feldman, M L Exum, A B Fleischer, D M Reboussin. J Am Acad Dermatol 1999
983
14

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Kim A Papp, Richard G Langley, Mark Lebwohl, Gerald G Krueger, Philippe Szapary, Newman Yeilding, Cynthia Guzzo, Ming-Chun Hsu, Yuhua Wang, Shu Li,[...]. Lancet 2008
14

The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.
Emmilia A Dowlatshahi, Marlies Wakkee, Lidia R Arends, Tamar Nijsten. J Invest Dermatol 2014
175
14


Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.
Kristian Reich, Frank O Nestle, Kim Papp, Jean-Paul Ortonne, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T Dooley, Christopher E M Griffiths. Lancet 2005
776
13

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
J-H Saurat, G Stingl, L Dubertret, K Papp, R G Langley, J-P Ortonne, K Unnebrink, M Kaul, A Camez. Br J Dermatol 2008
501
13

The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.
Florence J Dalgard, Uwe Gieler, Lucia Tomas-Aragones, Lars Lien, Francoise Poot, Gregor B E Jemec, Laurent Misery, Csanad Szabo, Dennis Linder, Francesca Sampogna,[...]. J Invest Dermatol 2015
336
13

Etanercept as monotherapy in patients with psoriasis.
Craig L Leonardi, Jerold L Powers, Robert T Matheson, Bernard S Goffe, Ralph Zitnik, Andrea Wang, Alice B Gottlieb. N Engl J Med 2003
870
12

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study.
Kenneth B Gordon, Richard G Langley, Craig Leonardi, Darryl Toth, M Alan Menter, Sewon Kang, Michael Heffernan, Bruce Miller, Regina Hamlin, Liberata Lim,[...]. J Am Acad Dermatol 2006
368
12

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).
Craig L Leonardi, Alexa B Kimball, Kim A Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T Dooley, Kenneth B Gordon. Lancet 2008
12


Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
S R Feldman, A B Gottlieb, M Bala, Y Wu, D Eisenberg, C Guzzo, S Li, L T Dooley, A Menter. Br J Dermatol 2008
61
19

An Italian study on psoriasis and depression.
Maria Esposito, Rosita Saraceno, Alessandro Giunta, Mara Maccarone, Sergio Chimenti. Dermatology 2006
142
12

Cytokine-associated emotional and cognitive disturbances in humans.
A Reichenberg, R Yirmiya, A Schuld, T Kraus, M Haack, A Morag, T Pollmächer. Arch Gen Psychiatry 2001
861
12


Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Shahin Akhondzadeh, Sara Jafari, Firoozeh Raisi, Abbas Ali Nasehi, Aboulfazl Ghoreishi, Bahman Salehi, Soodeh Mohebbi-Rasa, Maedeh Raznahan, Abbas Kamalipour. Depress Anxiety 2009
238
12

Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
Rosa Parisi, Deborah P M Symmons, Christopher E M Griffiths, Darren M Ashcroft. J Invest Dermatol 2013
12

Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.
R Gniadecki, D Robertson, C T Molta, B Freundlich, R Pedersen, W Li, R Boggs, A S Zbrozek. J Eur Acad Dermatol Venereol 2012
45
26

NSAIDs are associated with lower depression scores in patients with osteoarthritis.
Rupa L Iyengar, Sumeet Gandhi, Ashish Aneja, Kevin Thorpe, Louai Razzouk, Jeffery Greenberg, Serge Mosovich, Michael E Farkouh. Am J Med 2013
49
22

Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.
Tsuyoshi Miyaoka, Rei Wake, Motohide Furuya, Kristian Liaury, Masa Ieda, Kazunori Kawakami, Keiko Tsuchie, Michiyo Taki, Kotomi Ishihara, Tomoko Araki,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2012
136
11

Infliximab, a TNF-α antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level.
I Ertenli, S Ozer, S Kiraz, S B Apras, A Akdogan, O Karadag, M Calguneri, U Kalyoncu. Rheumatol Int 2012
75
14

Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
E Daudén, C E M Griffiths, J-P Ortonne, K Kragballe, C T Molta, D Robertson, R Pedersen, J Estojak, R Boggs. J Eur Acad Dermatol Venereol 2009
74
14


A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
K A Papp, S Tyring, M Lahfa, J Prinz, C E M Griffiths, A M Nakanishi, R Zitnik, P C M van de Kerkhof, Linda Melvin. Br J Dermatol 2005
513
10

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Edward V Loftus, Brian G Feagan, Jean-Frédéric Colombel, David T Rubin, Eric Q Wu, Andrew P Yu, Paul F Pollack, Jingdong Chao, Parvez Mulani. Am J Gastroenterol 2008
131
10

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Alan Menter, Alice Gottlieb, Steven R Feldman, Abby S Van Voorhees, Craig L Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y M Koo, Craig A Elmets, Neil J Korman,[...]. J Am Acad Dermatol 2008
823
10

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
Alan Menter, Steven R Feldman, Gerald D Weinstein, Kim Papp, Robert Evans, Cynthia Guzzo, Shu Li, Lisa T Dooley, Cynthia Arnold, Alice B Gottlieb. J Am Acad Dermatol 2007
339
10

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.
Jennifer L Warner-Schmidt, Kimberly E Vanover, Emily Y Chen, John J Marshall, Paul Greengard. Proc Natl Acad Sci U S A 2011
192
10


Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.
Joel M Gelfand, Alexa B Kimball, Eliot N Mostow, Chiun-Fang Chiou, Vaishali Patel, H Amy Xia, Bruce Freundlich, Seth R Stevens. Value Health 2008
49
20

Inflammation and clinical response to treatment in depression: A meta-analysis.
R Strawbridge, D Arnone, A Danese, A Papadopoulos, A Herane Vives, A J Cleare. Eur Neuropsychopharmacol 2015
289
10

A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy.
D G Fortune, H L Richards, B Kirby, S Bowcock, C J Main, C E M Griffiths. Br J Dermatol 2002
132
9

Risk of myocardial infarction in patients with psoriasis.
Joel M Gelfand, Andrea L Neimann, Daniel B Shin, Xingmei Wang, David J Margolis, Andrea B Troxel. JAMA 2006
9

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
Alice Gottlieb, Alan Menter, Alan Mendelsohn, Yaung-Kaung Shen, Shu Li, Cynthia Guzzo, Scott Fretzin, Rod Kunynetz, Arthur Kavanaugh. Lancet 2009
423
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.